<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01091922</url>
  </required_header>
  <id_info>
    <org_study_id>UReading-2009-01</org_study_id>
    <nct_id>NCT01091922</nct_id>
  </id_info>
  <brief_title>The Impact of Dietary Flavanols on the Gut Microflora</brief_title>
  <official_title>Prebiotic Evaluation of Cocoa-derived Flavanols in Healthy Humans Using a Randomized, Double Blind, Crossover, Placebo-controlled Intervention Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Reading</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Reading</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary propose of this study is to determine the impact of flavanol-rich cocoa on the
      growth of the human gut microbiota.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomised, placebo-controlled, double-blind, cross-over human intervention study will be
      conducted in 20 healthy human volunteers to test the impact of a high-flavanol containing
      meal on the growth of the large intestinal bacteria (microflora). The high flavanol test meal
      will contain 495 mg of flavanols and the low flavanol control will contain 23 mg of
      flavanols. The two intervention diets are otherwise matched for macro- and micronutrient
      content. Changes in the gut microbiota will be determined by measuring bacterial population
      levels in human faecal material using 16S rRNA targeted oligonucleotide probes and
      fluorescence in situ hybridization. A number of other biochemical and physiological measures
      will be recorded including blood glucose, lipoproteins, cytokine levels and blood pressure.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Faecal bacteria numbers using 16S rRNA targeted oligonucleotide probes analysis and fluorescence in situ hybridization</measure>
    <time_frame>baseline and 4 weeks</time_frame>
    <description>Measurements of the growth rate and number of bacterial species in human faecal samples using 16S rRNA targeted oligonucleotide probes and fluorescence in situ hybridisation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>Baseline, 4 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">22</enrollment>
  <condition>Intestinal Bacteria Growth</condition>
  <arm_group>
    <arm_group_label>Low Flavanol</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Low flavanol drink containing 23 mg of total flavanols. Macro- and micro-nutrient matched with active comparator</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High Flavanols</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>High Flavanol drink containing 495 mg of total flavanols</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Low flavanol cocoa beverage</intervention_name>
    <description>23 mg of total flavanols from cocoa</description>
    <arm_group_label>Low Flavanol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>High flavanol cocoa beverage</intervention_name>
    <description>495 mg of total flavanols from cocoa</description>
    <arm_group_label>High Flavanols</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  a signed consent form

          -  age of 18-50 years inclusive

          -  BMI between 20-26

        Exclusion Criteria:

          -  pregnant or lactating

          -  allergy to milk products

          -  sensitivity to alkaloids and/or caffeine

          -  gastrointestinal disorders (e.g., chronic constipation, diarrhoea, inflammatory bowel
             disease, -inflammatory bowel syndrome, or other chronic gastrointestinal complaints)

          -  diabetes mellitus

          -  hypertension (&gt;150/90 mm/Hg)

          -  anaemia and gall bladder problems

          -  not consuming probiotics, prebiotics, antibiotics or anti-inflammatory or blood
             lowering medication within a 2-month period prior to the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeremy Spencer, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Reading</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Reading</name>
      <address>
        <city>Reading</city>
        <state>Berkshire</state>
        <zip>RG2 9AR</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 23, 2010</study_first_submitted>
  <study_first_submitted_qc>March 23, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 24, 2010</study_first_posted>
  <last_update_submitted>March 23, 2010</last_update_submitted>
  <last_update_submitted_qc>March 23, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 24, 2010</last_update_posted>
  <responsible_party>
    <name_title>Dr Jeremy P E Spencer</name_title>
    <organization>University of Reading</organization>
  </responsible_party>
  <keyword>flavonoids</keyword>
  <keyword>flavanols</keyword>
  <keyword>bacteria</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

